Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("Knoll Pharmaceuticals")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 20 of 20

  • Page / 1
Export

Selection :

  • and

How should the obese patient be managed? Possible approaches to a national obesity management networkHAINER, V.International journal of obesity. Supplement. 1999, Vol 23, Num 4, pp S14-S19, issn 1359-6373Conference Paper

Steps towards the prevention of obesity and associated complicationsFALKENBERG, M.International journal of obesity. Supplement. 1999, Vol 23, Num 4, pp S20-S22, issn 1359-6373Conference Paper

How to tackle the problem early ? The role of education in the prevention of obesityDIETZ, W.International journal of obesity. Supplement. 1999, Vol 23, Num 4, pp S7-S9, issn 1359-6373Conference Paper

Early Intervention in Obesity: Implications for Impaired Glucose Tolerance. EASD/IDF Satellite SymposiumUUSITUPA, Matti; VAN GAAL, Luc.European journal of clinical investigation. Supplement. 1998, Vol 28, Num 2, issn 0960-135X, 32 p.Conference Proceedings

Intentional weight loss : patterns in the general population and its association with morbidity and mortalityWILLIAMSON, D. F.International journal of obesity. Supplement. 1997, Vol 21, Num 1, pp S14-S19, issn 1359-6373Conference Paper

Pharmacological approaches to interventionGUY-GRAND, B.International journal of obesity. Supplement. 1997, Vol 21, Num 1, pp S22-S24, issn 1359-6373Conference Paper

Sibutramine : a review of the pharmacology of a novel anti-obesity agentSTOCK, M. J.International journal of obesity. Supplement. 1997, Vol 21, Num 1, pp S25-S29, issn 1359-6373Conference Paper

Improvement of cadaver renal transplantation outcomes with verapamil : a reviewDAWIDSON, I; ROOTH, P.The American journal of medicine. 1991, Vol 90, Num 5A, pp 5A.37S-5A.41S, issn 0002-9343Conference Paper

Nonsteroidal anti-inflammatory drugs and antihypertensivesHOUSTON, M. C.The American journal of medicine. 1991, Vol 90, Num 5A, pp 5A.42S-5A.47S, issn 0002-9343Conference Paper

Who should be educated? Education strategies: could children educate their parents?BASDEVANT, A; BOUTE, D; BORYS, J. M et al.International journal of obesity. Supplement. 1999, Vol 23, Num 4, pp S10-S13, issn 1359-6373Conference Paper

Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients : blood pressure controle and immunosuppressionWEIR, M. R.The American journal of medicine. 1991, Vol 90, Num 5A, pp 5A.32S-5A.36S, issn 0002-9343Conference Paper

Sibutramine : a review of clinical efficacyLEAN, M. E. J.International journal of obesity. Supplement. 1997, Vol 21, Num 1, pp S30-S36, issn 1359-6373Conference Paper

Impact of age, race, and obesity on hypertensive mechanisms and therapyWEIR, M. R.The American journal of medicine. 1991, Vol 90, Num 5A, pp 5A.3S-5A.14S, issn 0002-9343Conference Paper

Verapamil and migraine porphylaxis : mechanisms and efficacyMARKLEY, H. G.The American journal of medicine. 1991, Vol 90, Num 5A, pp 5A.48S-5A.53S, issn 0002-9343Conference Paper

The benefits of modest weight loss in type II diabetesBOSELLO, O; ARMELLINI, F; ZAMBONI, M et al.International journal of obesity. Supplement. 1997, Vol 21, Num 1, pp S10-S13, issn 1359-6373Conference Paper

Emerging management strategies for obesity. DiscussionKOPELMAN, P; BRAY; FINER et al.International journal of obesity. Supplement. 1998, Vol 22, Num 1, pp S7-S12, issn 1359-6373Conference Paper

The beneficial effects of modest weight loss on cardiovascular risk factorsVAN GAAL, L; WAUTERS, M. A; DE LEEUW, I. H et al.International journal of obesity. Supplement. 1997, Vol 21, Num 1, pp S5-S9, issn 1359-6373Conference Paper

Sibutramine and energy balance. DiscussionASTRUP, A; HANSEN, D. L; LUNDSGAARD, C et al.International journal of obesity. Supplement. 1998, Vol 22, Num 1, pp S30-S37, issn 1359-6373Conference Paper

Sibutramine and fat distribution: Is there a role for pharmacotherapy in abdominal/visceral fat reduction? DiscussionVAN GAAL, L. F; WAUTERS, M. A; PEIFFER, F. W et al.International journal of obesity. Supplement. 1998, Vol 22, Num 1, pp S38-S41, issn 1359-6373Conference Paper

Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. DiscussionHEAL, D. J; ASPLEY, S; PROW, M. R et al.International journal of obesity. Supplement. 1998, Vol 22, Num 1, pp S18-S29, issn 1359-6373Conference Paper

  • Page / 1